LIfT BioSciences comes first for the UK, and second place in the whole of Europe out of more than 200 companies that qualified for entry...

LIfT BioSciences has received a significant investment in its mission to develop the first curative and affordable cell therapy for all...

LIfT BioSciences has been awarded Best Rising Start-Up at BioVaria 2018 by the experienced panel of judges, comprised of major Pharma...

LIfT BioSciences has successfully raised £300K in seed funding to help complete their cutting-edge laboratory work towards developing the...

Read full article here - Note: An inaccuracy in this article is that LIfT will use survivor donor cells. We will be recruiting donors...